Pacer Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-701
| Closed | -$7.61K | – | 2655 |
|
|
2024
Q2 | $7.61K | Sell |
701
-1,125
| -62% | -$12.2K | ﹤0.01% | 3565 |
|
|
2024
Q1 | $34.2K | Buy |
+1,826
| New | +$34.2K | ﹤0.01% | 3318 |
|
|
2021
Q2 | – | Sell |
-991
| Closed | -$74K | – | 1539 |
|
|
2021
Q1 | $74K | Sell |
991
-962
| -49% | -$71.8K | ﹤0.01% | 1352 |
|
|
2020
Q4 | $169K | Sell |
1,953
-950
| -33% | -$82.2K | ﹤0.01% | 1264 |
|
|
2020
Q3 | $177K | Buy |
+2,903
| New | +$177K | ﹤0.01% | 1199 |
|
|
2018
Q4 | – | Sell |
-1,653
| Closed | -$233K | – | 947 |
|
|
2018
Q3 | $233K | Buy |
+1,653
| New | +$233K | 0.01% | 999 |
|
|
2018
Q1 | – | Sell |
-825
| Closed | -$136K | – | 1116 |
|
|
2017
Q4 | $136K | Buy |
+825
| New | +$136K | 0.01% | 935 |
|